Based on the upregulation of IL-6 and JNK signaling identified in KD-induced MASH, we investigated whether inhibiting IL-6-gp130 signaling in the liver could rescue mice from KD-induced MASLD. The gene discussed is MAPK8; the disease is metabolic dysfunction-associated steatotic liver disease.